AlloSure Heart Clinical Validation Published in Leading Transplant Journal
The validation of AlloSure Heart to complement AlloMap is of great clinical importance, as the two tests together render a higher precision assessment of the heart allograft than either test alone.
“Standardization of surveillance use of HeartCare at heart transplant centers through SHORE will provide a powerful database to enable new understanding of how to imporve long term patient outcomes.” said
About
For more information, please visit: www.CareDx.com.
Forward Looking Statements
This press release includes forward-looking statements, including statements regarding the Company’s publication in
CONTACTS:
Chief Commercial Officer
415-287-2393
sking@caredx.com
Investor Relations
Integrated Corporate Relations, Inc.
646-277-1266
david.clair@icrinc.com
Source: CareDx, Inc.